Child Neurology Division, Department of Pediatrics, All India Institute of Medical Sciences, Delhi, India.
The INCLEN Trust International, 2nd Floor, F-1/5, Okhla Industrial Area, Phase-I, New Delhi, India.
Neurol India. 2020 Mar-Apr;68(2):352-357. doi: 10.4103/0028-3886.280638.
The current study was planned at a tertiary centre in northern India to develop and validate a Diagnostic and Statistical Manual-5 (DSM-5)-based diagnostic tool and design a severity score for attention deficit hyperactivity disorder (ADHD) in children aged 6-18 years. An existing DSM-IV-based tool, INDT (International Clinical Epidemiology Network [INCLEN] diagnostic tool) for ADHD has been modified and named All India Institute of Medical Sciences (AIIMS)-modified INDT ADHD tool.
The first phase was development of the tool and the second phase was validation of the same against the gold standard of diagnosis by the DSM-5. A severity score was developed for ADHD in concordance with the Conners rating scale.
The tool was validated in 66 children with a sensitivity and specificity of 100 per cent and 90 per cent, respectively. A cut-off score of 12 was decided for labelling severity of ADHD, which corresponded to 63 in the Conners rating scale.
This diagnostic tool for ADHD based on DSM-5 has acceptable psychometric properties. The severity score will be useful for prognostication, monitoring treatment response, and designing intervention trials.
本研究在印度北部的一家三级中心进行，旨在开发和验证基于《精神障碍诊断与统计手册第五版》（DSM-5）的诊断工具，并为 6-18 岁儿童设计注意力缺陷多动障碍（ADHD）严重程度评分。现有的基于 DSM-IV 的 ADHD 诊断工具 INDT（国际临床流行病学网络 [INCLEN] 诊断工具）已被修改，并命名为全印度医学科学研究所（AIIMS）-改良 INDT ADHD 工具。
第一阶段是开发工具，第二阶段是根据 DSM-5 的金标准对其进行验证。根据 Conners 评定量表，为 ADHD 制定了严重程度评分。
该工具在 66 名儿童中进行了验证，其敏感性和特异性分别为 100%和 90%。将 ADHD 的严重程度标记为 12 分，这与 Conners 评定量表中的 63 分相对应。
基于 DSM-5 的 ADHD 诊断工具具有可接受的心理测量特性。严重程度评分将有助于预测、监测治疗反应和设计干预试验。
